相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal study
Zheyu Xu et al.
JOURNAL OF NEUROLOGY (2021)
Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders
Malvika Kaul et al.
NEUROTHERAPEUTICS (2021)
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
Carlos M. O. de Almeida et al.
MOVEMENT DISORDERS (2021)
Sleep in Parkinson's disease
Ambra Stefani et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia S. Suraev et al.
SLEEP MEDICINE REVIEWS (2020)
Non-Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
Marina Peball et al.
ANNALS OF NEUROLOGY (2020)
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
Marina Peball et al.
JOURNAL OF NEURAL TRANSMISSION (2019)
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Klaus Seppi et al.
MOVEMENT DISORDERS (2019)
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system
Maria S. Aymerich et al.
BIOCHEMICAL PHARMACOLOGY (2018)
The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naive Parkinson's disease
Sonja Rutten et al.
PARKINSONISM & RELATED DISORDERS (2017)
The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice
Giuseppe Loddo et al.
FRONTIERS IN NEUROLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Medicinal Cannabis for Parkinson's Disease: Practices, Beliefs, and Attitudes Among Providers at National Parkinson Foundation Centers of Excellence
Danny Bega et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Endocannabinoid system: Role in depression, reward and pain control (Review)
Wen-Juan Huang et al.
MOLECULAR MEDICINE REPORTS (2016)
Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa
Italo Biaggioni et al.
HYPERTENSION (2015)
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
M. H. N. Chagas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs
Daniel Lakens
FRONTIERS IN PSYCHOLOGY (2013)
Validation of the MDS-UPDRS Part I for Nonmotor Symptoms in Parkinson's Disease
David A. Gallagher et al.
MOVEMENT DISORDERS (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using F-18-Labeled Inverse Agonist Radioligands
Garth E. Terry et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Selectivity in rodents and monkeys of 11C-CUMI-101, an agonist radioligand for serotonin 5-HT1A receptors
Jeih-San Liow et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
分享论文
